MedCity News February 25, 2025
Thermo Fisher Scientific agreed to acquire the Purification and Filtration business of 3M spinoff Solventum. Filters and membranes from this business segment are used globally in applications such as biopharmaceutical manufacturing.
Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides technologies and products used in the manufacturing of biologic drugs.
Under deal terms announced Tuesday, Thermo Fisher will pay $4.1 billion in cash for Solventum’s Purification and Filtration, a business segment that has about 2,500 employees throughout the world. Waltham, Massachusetts-based Thermo Fisher described this Solventum business as complementary to its own bioproduction business. The deal is expected to close by the end of this year.
Solventum is relatively young, having spun...
Today's Sponsors
Today's Sponsor